Skip to main content
Top
Published in: The Patient - Patient-Centered Outcomes Research 3/2008

01-07-2008 | Original Research Article

Obesity and Symptom Burden in Family Medicine Patients

Authors: Professor James E. Rohrer, Norman H. Rasmussen, Margaret S. Houston, Kurt B. Angstman

Published in: The Patient - Patient-Centered Outcomes Research | Issue 3/2008

Login to get access

Abstract

Background: Medical visits are initiated by patients in search of symptom relief. The extent to which obesity independently increases the risk of common symptoms is unknown.
Objectives: To assess how obesity affects symptom burden among family medicine patients, after adjustment for severity of illness, via retrospective analysis of electronic medical records pertaining to 1738 adult family medicine patients treated in a large family medicine department in Rochester, Minnesota, USA.
Methods: A symptom index was used to measure symptom burden. Body mass index (BMI; kg/m2) was measured during clinic visits. Multiple logistic regression analysis was used to test for an independent relationship between BMI category and the presence of three or more common symptoms. p ]Results: Adjusting for co-morbidity and other confounders using multiple logistic regression analysis revealed that having a BMI ≥35 kg/m2 was independently related to symptom burden (adjusted odds ratio [OR] = 1.80; 95% CI 1.24, 2.63). Patients with low and moderate co-morbidities (as measured by the Charlson Comorbidity Index) also had higher odds of reporting more symptoms (OR = 1.60; 95% CI 1.17, 2.17 and OR = 1.87; 95% CI 1.36, 2.56, respectively). Symptom burden increased with age. Odds of having three or more symptoms were lower for married patients (OR 0.63; 95% CI 0.47, 0.83).
Conclusions: In our sample of family medicine patients, increased symptom burden may be associated with a BMI ≥35 kg/m2. Lower levels of obesity do not appear to be related to symptom burden.
Literature
1.
go back to reference Patterson R, Frank L, Kristal A, et al. A comprehensive examination of health conditions associated with obesity in older adults. Am J Prev Med 2004 Dec; 27(5): 385–90PubMedCrossRef Patterson R, Frank L, Kristal A, et al. A comprehensive examination of health conditions associated with obesity in older adults. Am J Prev Med 2004 Dec; 27(5): 385–90PubMedCrossRef
2.
go back to reference Rohrer J, Adamson S, Barnes D, et al. Obesity and general pain in patients utilizing family medicine: should pain standards call for referral of obese patients to weight management programs? Qual Manag Health Care 2008 Jul–Sep; 17(3): 204–9PubMed Rohrer J, Adamson S, Barnes D, et al. Obesity and general pain in patients utilizing family medicine: should pain standards call for referral of obese patients to weight management programs? Qual Manag Health Care 2008 Jul–Sep; 17(3): 204–9PubMed
3.
go back to reference Rohrer J, Bartel G, Adamson S, et al. Change in body mass index over 1 year in a family medicine clinic: a retrospective analysis of medical records. J Clin Outcomes Manage 2008; 15(2): 1–5 Rohrer J, Bartel G, Adamson S, et al. Change in body mass index over 1 year in a family medicine clinic: a retrospective analysis of medical records. J Clin Outcomes Manage 2008; 15(2): 1–5
4.
go back to reference Crane HM, Van Rompaey SE, Dillingham PW, et al. A single-item measure of health-related quality-of-life for HIV-infected patients in routine clinical care. AIDS Patient Care Stds Mar 2006; 20(3): 161–74CrossRef Crane HM, Van Rompaey SE, Dillingham PW, et al. A single-item measure of health-related quality-of-life for HIV-infected patients in routine clinical care. AIDS Patient Care Stds Mar 2006; 20(3): 161–74CrossRef
5.
go back to reference Mao JJ, Armstrong K, Bowman MA, et al. Symptom burden among cancer survivors: impact of age and comorbidity. J Am Board Fam Med Sep–Oct 2007; 20(5): 434–43PubMedCrossRef Mao JJ, Armstrong K, Bowman MA, et al. Symptom burden among cancer survivors: impact of age and comorbidity. J Am Board Fam Med Sep–Oct 2007; 20(5): 434–43PubMedCrossRef
6.
go back to reference Helenius IM, Korenstein D, Halm EA. Changing use of hormone therapy among minority women since the Women’s Health Initiative. Menopause 2007; 14(2): 216–22PubMedCrossRef Helenius IM, Korenstein D, Halm EA. Changing use of hormone therapy among minority women since the Women’s Health Initiative. Menopause 2007; 14(2): 216–22PubMedCrossRef
7.
go back to reference Sarkar U, Ali S, Whooley MA. Self-efficacy and health status in patients with coronary heart disease: findings from the Heart and Soul study. Psychosom Med 2007; 69(4): 306–12PubMedCrossRef Sarkar U, Ali S, Whooley MA. Self-efficacy and health status in patients with coronary heart disease: findings from the Heart and Soul study. Psychosom Med 2007; 69(4): 306–12PubMedCrossRef
8.
go back to reference Wexler R. Treatment of hypertension critical in reducing morbidity and mortality [letter]. J Am Board Fam Med 2007; 20(3): 322PubMedCrossRef Wexler R. Treatment of hypertension critical in reducing morbidity and mortality [letter]. J Am Board Fam Med 2007; 20(3): 322PubMedCrossRef
9.
go back to reference Viera A, Jamieson B, Dealleaume L. How effective are hypertension self-care interventions? J Fam Pract 2007; 56(3): 229–31PubMed Viera A, Jamieson B, Dealleaume L. How effective are hypertension self-care interventions? J Fam Pract 2007; 56(3): 229–31PubMed
10.
go back to reference Truby H, Baic S, deLooy A, et al. Randomised controlled trial of four commercial weight loss programmes in the UK: initial findings from the BBC ‘diet trials’. BMJ 2006 Jun 3; 332(7553): 1309–14PubMedCrossRef Truby H, Baic S, deLooy A, et al. Randomised controlled trial of four commercial weight loss programmes in the UK: initial findings from the BBC ‘diet trials’. BMJ 2006 Jun 3; 332(7553): 1309–14PubMedCrossRef
11.
go back to reference Charlson M, Pompei P, Ales K, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40(5): 373–83PubMedCrossRef Charlson M, Pompei P, Ales K, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40(5): 373–83PubMedCrossRef
12.
go back to reference Chaudhry S, Jin L, Meltzer D. Use of a self-report-generated Charlson Comorbidity Index for predicting mortality. Med Care 2005 Jun; 43(6): 607–15PubMedCrossRef Chaudhry S, Jin L, Meltzer D. Use of a self-report-generated Charlson Comorbidity Index for predicting mortality. Med Care 2005 Jun; 43(6): 607–15PubMedCrossRef
13.
go back to reference Rohrer J, Rasmussen N, Adamson S. Illness severity and total visits in family medicine. J Eval Clin Pract 2008; 14: 65–9PubMedCrossRef Rohrer J, Rasmussen N, Adamson S. Illness severity and total visits in family medicine. J Eval Clin Pract 2008; 14: 65–9PubMedCrossRef
14.
go back to reference Kroenke K, Price RK. Symptoms in the community: prevalence, classification, and psychiatric comorbidity. Arch Int Med 1993; 153(21): 2474–80CrossRef Kroenke K, Price RK. Symptoms in the community: prevalence, classification, and psychiatric comorbidity. Arch Int Med 1993; 153(21): 2474–80CrossRef
15.
go back to reference Kroenke K. Patients presenting with somatic complaints: epidemiology, psychiatric comorbidity and management. Int J Methods Psych Res 2003; 12(1): 34–43CrossRef Kroenke K. Patients presenting with somatic complaints: epidemiology, psychiatric comorbidity and management. Int J Methods Psych Res 2003; 12(1): 34–43CrossRef
16.
go back to reference Jackson JL, Houston JS, Hanling SR, et al. Clinical predictors of mental disorders among medical outpatients. Arch Int Med 2001; 161(6): 875–9CrossRef Jackson JL, Houston JS, Hanling SR, et al. Clinical predictors of mental disorders among medical outpatients. Arch Int Med 2001; 161(6): 875–9CrossRef
17.
go back to reference Cramer V, Torgersen S, Kringlen E. Socio-demographic conditions, subjective somatic health, Axis I disorders and personality disorders in the common population: the relationship to quality of life. J Personal Disord 2007; 21(5): 552–67CrossRef Cramer V, Torgersen S, Kringlen E. Socio-demographic conditions, subjective somatic health, Axis I disorders and personality disorders in the common population: the relationship to quality of life. J Personal Disord 2007; 21(5): 552–67CrossRef
18.
go back to reference Kaplan RM. Application of a general health policy model in the American health care crisis. J R Soc Med 1993; 86(5): 277–81PubMed Kaplan RM. Application of a general health policy model in the American health care crisis. J R Soc Med 1993; 86(5): 277–81PubMed
19.
go back to reference McDowell I, Newell C. The Quality of Well-Being Scale (formerly the Index of Well-Being). In: McDowell I, Newell C, editors. Measuring health: a guide to rating scales and questionnaires. 2nd ed. New York: Oxford University Press, 1996: 483–92 McDowell I, Newell C. The Quality of Well-Being Scale (formerly the Index of Well-Being). In: McDowell I, Newell C, editors. Measuring health: a guide to rating scales and questionnaires. 2nd ed. New York: Oxford University Press, 1996: 483–92
Metadata
Title
Obesity and Symptom Burden in Family Medicine Patients
Authors
Professor James E. Rohrer
Norman H. Rasmussen
Margaret S. Houston
Kurt B. Angstman
Publication date
01-07-2008
Publisher
Springer International Publishing
Published in
The Patient - Patient-Centered Outcomes Research / Issue 3/2008
Print ISSN: 1178-1653
Electronic ISSN: 1178-1661
DOI
https://doi.org/10.2165/1312067-200801030-00003

Other articles of this Issue 3/2008

The Patient - Patient-Centered Outcomes Research 3/2008 Go to the issue

Pioneer Profile

Erik Rifkin, PhD

Original Research Article

The Burden of Restless Legs Syndrome

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine